Undifferentiated Pleomorphic Sarcoma: Long-Term Follow-Up from a Large Institution
Open Access
- 1 November 2019
- journal article
- research article
- Published by Taylor & Francis Ltd in Cancer Management and Research
- Vol. ume 11, 10001-10009
- https://doi.org/10.2147/cmar.s226896
Abstract
Purpose: Our study aimed to describe the clinical features of undifferentiated pleomorphic sarcoma (UPS) and identify the predictors of poor outcomes. Patients and methods: The clinicopathological variables and treatment strategies of 100 UPS patients who underwent surgical resections at a single institution between November 2004 and July 2016 were reviewed. Kaplan–Meier and Cox regression method were conducted for survival analysis. Results: The median follow-up time was 94 months (range, 1.5–154 months). R0 resection was applied for 72 cases, and the median tumor size was 5.75cm (range, 1–30cm). Tumor grades of 45 patients were intermediate grade (G2), and 54 patients were with advanced stage (stage III/IV). Twenty-seven patients presented with tumors involving important structures, in which the nerve was the most frequently invaded structure (n=12). During the follow-up, 40 patients suffered from postoperative local recurrence, and distant metastasis was observed in 25 patients which mainly metastasized to the lung (n=14). The 5-year OS rate, 5-year LRFS rate, and 5-year MFS rate was 53%, 55%, and 70%, respectively. Multivariate analysis revealed that tumor presentation, tumor size, and important structures involved (p=0.033, p=0.004, and p=0.033, respectively) were independent prognostic factors associated with OS. Meanwhile, age, resection quality and tumor grade were independent prognostic factors for LRFS (p=0.033, p=0.045, and p=0.007, respectively) and tumor depth was significantly associated with MFS (p=0.050) in multivariate analysis. Conclusion: Primary treatment of UPS should be conducted by experts in large sarcoma center. Wide surgical margin provides sufficient control of the disease recurrence.Keywords
This publication has 30 references indexed in Scilit:
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- Size Matters for Sarcomas!The Annals of The Royal College of Surgeons of England, 2006
- Malignant fibrous histiocytoma: Outcome of tumours in the head and neck compared with those in the trunk and extremitiesBritish Journal of Oral and Maxillofacial Surgery, 2006
- Classification of pleomorphic sarcomas: where are we now?Histopathology, 2005
- Treatment results and prognostic factors in patients with malignant fibrous histiocytomaActa Oncologica, 2004
- Current soft-tissue sarcoma classificationsEuropean Journal of Cancer, 2004
- Malignant fibrous histiocytoma of the extremities and trunk: An institutional reviewSurgery, 2004
- Malignant Fibrous HistiocytomaAmerican Journal of Clinical Oncology, 2002
- Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading systemInternational Journal of Cancer, 1984